Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
392
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
2
Trials by status
Completed
1
Unknown
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's Diseasemild-to-moderate ADN/AUnknown150
Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's DiseaseMMSE ≤14Ph 4Unknown150
DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving DonepezilAlzheimer's diseaseN/ACompleted92